Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings. (2020)
Attributed to:
King's Health Partners Confidence in Concept
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.ppat.1008817
PubMed Identifier: 32970782
Publication URI: http://europepmc.org/abstract/MED/32970782
Type: Journal Article/Review
Volume: 16
Parent Publication: PLoS pathogens
Issue: 9
ISSN: 1553-7366